BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37709352)

  • 1. Performance of Neck Imaging Reporting and Data System (NI-RADS) for Diagnosis of Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
    Baba A; Kurokawa R; Kurokawa M; Yanagisawa T; Srinivasan A
    AJNR Am J Neuroradiol; 2023 Oct; 44(10):1184-1190. PubMed ID: 37709352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective Evaluation of NI-RADS for Detecting Postsurgical Recurrence of Oral Squamous Cell Carcinoma on Surveillance CT or MRI.
    Dinkelborg P; Ro SR; Shnayien S; Schaafs LA; Koerdt S; Kreutzer K; Heiland M; Hamm B; Elsholtz FHJ
    AJR Am J Roentgenol; 2021 Jul; 217(1):198-206. PubMed ID: 32876497
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic accuracy of NI-RADS for prediction of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
    Li W; Sun Y; Shang W; Xu H; Zhang H; Lu F
    Radiol Med; 2024 Jan; 129(1):70-79. PubMed ID: 37904037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neck Imaging Reporting and Data System Category 3 on Surveillance Computed Tomography: Incidence, Biopsy Rate, and Predictive Performance in Head and Neck Squamous Cell Carcinoma.
    Johansson ED; Hughes RT; Meegalla NT; Porosnicu M; Patwa HS; Lack CM; Bunch PM
    Laryngoscope; 2022 Sep; 132(9):1792-1797. PubMed ID: 35043989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interreader reproducibility of the Neck Imaging Reporting and Data system (NI-RADS) lexicon for the detection of residual/recurrent disease in treated head and neck squamous cell carcinoma (HNSCC).
    Abdelaziz TT; Abdel Razk AAK; Ashour MMM; Abdelrahman AS
    Cancer Imaging; 2020 Aug; 20(1):61. PubMed ID: 32811559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.
    Krieger DA; Hudgins PA; Nayak GK; Baugnon KL; Corey AS; Patel MR; Beitler JJ; Saba NF; Liu Y; Aiken AH
    AJNR Am J Neuroradiol; 2017 Jun; 38(6):1193-1199. PubMed ID: 28364010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding MR Diffusion Imaging and T2 Signal Intensity to Neck Imaging Reporting and Data System Categories 2 and 3 in Primary Sites of Postsurgical Oral Cavity Carcinoma Provides Incremental Diagnostic Value.
    Jajodia A; Mandal G; Yadav V; Khoda J; Goyal J; Pasricha S; Puri S; Dewan A
    AJNR Am J Neuroradiol; 2022 Jul; 43(7):1018-1023. PubMed ID: 35738671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of double reading on NI-RADS diagnostic accuracy in reporting oral squamous cell carcinoma surveillance imaging - a single-center study.
    Elsholtz FHJ; Ro SR; Shnayien S; Dinkelborg P; Hamm B; Schaafs LA
    Dentomaxillofac Radiol; 2022 Jan; 51(1):20210168. PubMed ID: 34233509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of Response Assessment FDG-PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI-RADS.
    Paul S; Gupta T; Purandare N; Joshi K; Ghosh-Laskar S; Budrukkar A; Swain M; Sinha S; Kumar A; Joshi A; Prabhash K; Nair S; Rangarajan V; Agarwal JP
    Otolaryngol Head Neck Surg; 2023 Oct; 169(4):938-947. PubMed ID: 36856038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI Posttreatment Surveillance for Head and Neck Squamous Cell Carcinoma: Proposed MR NI-RADS Criteria.
    Ashour MM; Darwish EAF; Fahiem RM; Abdelaziz TT
    AJNR Am J Neuroradiol; 2021 Jun; 42(6):1123-1129. PubMed ID: 33707288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Value of First Posttreatment Imaging Using Standardized Reporting in Head and Neck Cancer.
    Hsu D; Chokshi FH; Hudgins PA; Kundu S; Beitler JJ; Patel MR; Aiken AH
    Otolaryngol Head Neck Surg; 2019 Dec; 161(6):978-985. PubMed ID: 31331239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative Predictive Value of NI-RADS Category 2 in the First Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.
    Wangaryattawanich P; Branstetter BF; Hughes M; Clump DA; Heron DE; Rath TJ
    AJNR Am J Neuroradiol; 2018 Oct; 39(10):1884-1888. PubMed ID: 30166429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrater Reliability of NI-RADS on Posttreatment PET/Contrast-enhanced CT Scans in Head and Neck Squamous Cell Carcinoma.
    Hsu D; Rath TJ; Branstetter BF; Anzai Y; Phillips CD; Juliano AF; Mosier KM; Bazylewicz MP; Poliashenko SM; Kulzer MH; Rhyner PA; Risk B; Wiggins RH; Aiken AH
    Radiol Imaging Cancer; 2021 May; 3(3):e200131. PubMed ID: 34018845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the Neck Imaging Reporting and Data System as applied by general neuroradiologists to predict recurrence of head and neck cancers.
    Lee J; Kaht D; Ali S; Johnson S; Bullen J; Karakasis C; Lamarre E; Geiger J; Koyfman S; Stock S
    Head Neck; 2022 Oct; 44(10):2257-2264. PubMed ID: 35801334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACR Neck Imaging Reporting and Data Systems (NI-RADS): A White Paper of the ACR NI-RADS Committee.
    Aiken AH; Rath TJ; Anzai Y; Branstetter BF; Hoang JK; Wiggins RH; Juliano AF; Glastonbury C; Phillips CD; Brown R; Hudgins PA
    J Am Coll Radiol; 2018 Aug; 15(8):1097-1108. PubMed ID: 29983244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Diagnostic Value of Diffusion-Weighted Imaging in Differentiating Metastatic Lymph Nodes of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Suh CH; Choi YJ; Baek JH; Lee JH
    AJNR Am J Neuroradiol; 2018 Oct; 39(10):1889-1895. PubMed ID: 30213809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.
    Baugnon KL
    Neuroimaging Clin N Am; 2022 Feb; 32(1):1-18. PubMed ID: 34809832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NI-RADS for head and neck cancer surveillance imaging: What, why, and how.
    Juliano AF; Aiken AH
    Cancer Cytopathol; 2020 Mar; 128(3):166-170. PubMed ID: 31750995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best Practices: Application of NI-RADS for Posttreatment Surveillance Imaging of Head and Neck Cancer.
    Strauss SB; Aiken AH; Lantos JE; Phillips CD
    AJR Am J Roentgenol; 2021 Jun; 216(6):1438-1451. PubMed ID: 32876470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neck Imaging Reporting and Data System: What Does Radiologist Want to Know?
    Abdel Razek AAK; Abdelaziz TT
    J Comput Assist Tomogr; 2020; 44(4):527-532. PubMed ID: 32467486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.